Ureteral Stent Exchange Abstention in Urinary Tract Infections
NCT ID: NCT06503588
Last Updated: 2025-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-07-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relevance of the Urine Bacterial Culture Performed Before Double J Ablation for Post-operative Urinary Tract Infection Prevention
NCT04913753
Antibiotic Prophylaxis for Clean Intermittent Catheterisation
NCT02145338
Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.
NCT05534399
Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting
NCT05091931
Profiles of Urinary Tract Infections in General Practice
NCT05847036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before guidelines
Patients treated for ureteral stent associated urinary tract infection in the University Hospital of Nancy from January 1, 2018 to May 31, 2020
No interventions assigned to this group
After guidelines
Patients treated for ureteral stent associated urinary tract infection in the University Hospital of Nancy from August 1, 2020 to December 31, 2022
Guidelines promoting surgical abstention
Guidelines promoting surgical abstention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guidelines promoting surgical abstention
Guidelines promoting surgical abstention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* AND confirmed or probable urinary tract infection
Exclusion Criteria
* History of ileal conduit urinary diversion
* Second or more urinary tract infection during the study period
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LEFEVRE Benjamin
MD. PhD.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
+33383154097 Lefevre, M.D. PhD
Role: PRINCIPAL_INVESTIGATOR
Central Hospital, Nancy, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nancy university hospital
Nancy, Lorraine, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022PI037
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.